Immune suppressive mechanisms in the tumor microenvironment
- 1 April 2016
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 39, 1-6
- https://doi.org/10.1016/j.coi.2015.10.009
Abstract
No abstract availableKeywords
Funding Information
- Italian Ministry of Health (FINALIZZATA 2011-2012 RF-2011-02348435 cup: E35G1400019001)
- Italian Ministry of Education, Universities and Research (B31J11000420001)
- Italian Association for Cancer Research (AIRC 6599, 12182 and 14103)
- NIH (R01CA096651 and R01CA103320)
This publication has 56 references indexed in Scilit:
- The PTEN pathway in T regs is a critical driver of the suppressive tumor microenvironmentScience Advances, 2015
- Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell ResponsesImmunity, 2015
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpectedJCI Insight, 2015
- Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugsBlood, 2015
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunityNature, 2015
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patientsNature, 2014
- Regulatory T cells in cancer immunotherapyCurrent Opinion in Immunology, 2014
- The wound healing, chronic fibrosis, and cancer progression triadPhysiological Genomics, 2014
- Aire-Dependent Thymic Development of Tumor-Associated Regulatory T CellsScience, 2013
- GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-DioxygenaseImmunity, 2005